Brodsky & Smith News Releases

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lifecore Biomedical, Inc. (LFCR)

Tue, 29 Sep 2026 11:00:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - September 29, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Lifecore Biomedical, Inc. ("Lifecore Biomedical" or the "Company") (NASDAQ: LFCR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Webster Equity Partners for $6.28 per share in cash at closing plus one non-tradable contingent value...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of ACV Auctions Inc. (ACVA)

Fri, 11 Sep 2026 16:09:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - September 11, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of ACV Auctions Inc. ("ACV" or the "Company") (NYSE: ACVA) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Copart, Inc. (NASDAQ: CPRT) for $10.50 per share in cash, representing an implied equity value of approximately $1.9 billion.The...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Beazer Homes USA, Inc. (BZH)

Wed, 26 Aug 2026 12:12:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - August 26, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Beazer Homes USA, Inc. ("Bowman" or the "Company") (NYSE: BZH) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Dream Finders Homes, Inc. (NYSE: DFH) for $33.50 for each share of Beazer common stock in an all-cash transaction at an...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Beazer Homes USA, Inc. (BZH)

Tue, 11 Aug 2026 16:08:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Beazer Homes USA, Inc. ("Bowman" or the "Company") (NYSE: BZH) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Dream Finders Homes, Inc. (NYSE: DFH) for $33.50 for each share of Beazer common stock in an all-cash transaction at an...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Finward Bancorp (FNWD)

Thu, 23 Jul 2026 15:33:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - July 23, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Finward Bancorp ("Finward" or the "Company") (NASDAQ: FNWD) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to First Financial Bancorp. (NASDAQ: FFBC) in an all-stock transaction where each outstanding share of Finward common stock will be...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)

Tue, 07 Jul 2026 09:28:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - July 7, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Crinetics Pharmaceuticals, Inc. ("Crinetics Pharmaceuticals" or the "Company") (NASDAQ: CRNX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) for $85.00 per share in cash, for a total...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Lisata Therapeutics, Inc. (LSTA)

Mon, 15 Jun 2026 16:53:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 15, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Lisata Therapeutics, Inc. ("Lisata Therapeutics" or the "Company") (NASDAQ - LSTA) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kuva Labs, Inc. ("Kuva") for $4.00 per share in cash plus two non-tradeable contingent value rights (CVRs),...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN)

Tue, 02 Jun 2026 12:05:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - June 2, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Organon & Co. ("Organon" or the "Company") (NYSE - OGN) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited for $14.00 per share in an all-cash transaction with an enterprise valuation of $11.75...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LiveRamp Holdings, Inc. (RAMP)

Tue, 19 May 2026 17:42:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - May 19, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of LiveRamp Holdings, Inc. ("LiveRamp" or the "Company") (NYSE: RAMP) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Publicis Groupe for a total enterprise value of $2.167 billion in an all-cash transaction, based on an acquisition price of...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of UniFirst Corporation (UNF)

Wed, 11 Mar 2026 15:14:00 -0400

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 11, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of UniFirst Corporation ("UniFirst" or the "Company") (NYSE: UNF) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Cintas Corporation (NASDAQ: CTAS) for $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share they own,...